Abiopharma

New Form 8-K - Electromed, Inc. Filed: 2025-09-09 AccNo: 0001437749-25-028605 Size: 170 KB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

SmartVest - Electromed, Inc. Announces Share Repurchase Authorization

CLISEQ, 10X Genomics and Weizmann Institute to Investigate Single Cell Applications in Hematology Clinical Diagnostics

Moleculin Accelerates Recruitment in Phase 3 Acute Myeloid Leukemia "MIRACLE" Clinical Trial

New Form 6-K - Haleon plc Filed: 2025-09-09 AccNo: 0001654954-25-010518 Size: 39 KB

New Form 8-K - Moleculin Biotech, Inc. Filed: 2025-09-09 AccNo: 0001437749-25-028604 Size: 239 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

Volition Signs First Human Out Licensing Deal

New Form DEFA14A - INTENSITY THERAPEUTICS, INC. Filed: 2025-09-09 AccNo: 0001567264-25-000091 Size: 1 MB

New Form DEF 14A - INTENSITY THERAPEUTICS, INC. Filed: 2025-09-09 AccNo: 0001567264-25-000090 Size: 1 MB

New Form 8-K/A - Strawberry Fields REIT, Inc. Filed: 2025-09-09 AccNo: 0001493152-25-012849 Size: 381 KB Item 9.01: Financial Statements and Exhibits

Citius Oncology - Citius Oncology Announces Pricing of $9.0 Million Registered Direct Offering and Concurrent Private Placement

Tiziana Life Sciences Announces Purchase of Shares by Chief Executive Officer

Elutia Announces Sale of BioEnvelope Business to Boston Scientific Corporation for $88 Million

Vistagen to Present at the TD Cowen 5th Annual Novel Mechanisms in Neuropsychiatry & Epilepsy Summit

Quoin Pharmaceuticals Releases Fifth NETHERTON NOW Video Featuring Writers and Influencers Allie and Kaleigh Fasanella, Twin Sisters Living with Netherton Syndrome